1. Home
  2. CTSO vs ARAI Comparison

CTSO vs ARAI Comparison

Compare CTSO & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.46

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

ARAI

Arrive AI Inc.

HOLD

Current Price

$0.48

Market Cap

25.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
ARAI
Founded
1997
2020
Country
United States
United States
Employees
N/A
51
Industry
Medical/Dental Instruments
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
25.1M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
ARAI
Price
$0.46
$0.48
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$12.00
AVG Volume (30 Days)
209.1K
1.1M
Earning Date
05-01-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
$800.66
Revenue Next Year
$22.41
$650.00
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.37
$0.40
52 Week High
$1.39
$12.85

Technical Indicators

Market Signals
Indicator
CTSO
ARAI
Relative Strength Index (RSI) 45.56 38.84
Support Level $0.37 $0.40
Resistance Level $0.72 $0.78
Average True Range (ATR) 0.06 0.07
MACD 0.01 0.00
Stochastic Oscillator 35.57 30.72

Price Performance

Historical Comparison
CTSO
ARAI

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: